Tibolone protects T98G cells from glucose deprivation

J Steroid Biochem Mol Biol. 2014 Oct:144 Pt B:294-303. doi: 10.1016/j.jsbmb.2014.07.009. Epub 2014 Jul 31.

Abstract

The steroidal drug Tibolone is used for the treatment of climacteric symptoms and osteoporosis in post-menopausal women. Although Tibolone has been shown to exert neuroprotective actions after middle cerebral artery occlusion, its specific actions on glial cells have received very little attention. In the present study we have assessed whether Tibolone exerts protective actions in a human astrocyte cell model, the T98G cells, subjected to glucose deprivation. Our findings indicate that Tibolone decreases the effects of glucose deprivation on cell death, nuclear fragmentation, superoxide ion production, mitochondrial membrane potential, cytoplasmic calcium concentration and morphological parameters. These findings suggest that glial cells may participate in the neuroprotective actions of Tibolone in the brain.

Keywords: Estrogenic activity; Free radicals; Metabolic insult; Neuroprotection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Astrocytes / drug effects*
  • Astrocytes / metabolism
  • Astrocytes / physiology
  • Calcium / metabolism
  • Cell Death / drug effects
  • Cell Line
  • Estrogen Receptor Modulators / pharmacology*
  • Glucose / metabolism*
  • Humans
  • Membrane Potential, Mitochondrial / drug effects
  • Neuroprotective Agents / pharmacology*
  • Norpregnenes / pharmacology*
  • Reactive Oxygen Species / metabolism

Substances

  • Estrogen Receptor Modulators
  • Neuroprotective Agents
  • Norpregnenes
  • Reactive Oxygen Species
  • tibolone
  • Glucose
  • Calcium